Abstract
The current practice for diagnosis of COVID-19, based on SARS-CoV-2 PCR testing of pharyngeal or respiratory specimens in a symptomatic patient at high epidemiologic risk, likely underestimates the true prevalence of infection. Serologic methods can more accurately estimate the disease burden by detecting infections missed by the limited testing performed to date. Here, we describe the validation of a coronavirus antigen microarray containing immunologically significant antigens from SARS-CoV-2, in addition to SARS-CoV, MERS-CoV, common human coronavirus strains, and other common respiratory viruses. A comparison of antibody profiles detected on the array from control sera collected prior to the SARS-CoV-2 pandemic versus convalescent blood specimens from virologically confirmed COVID-19 cases demonstrates near complete discrimination of these two groups, with improved performance from use of antigen combinations that include both spike protein and nucleoprotein. This array can be used as a diagnostic tool, as an epidemiologic tool to more accurately estimate the disease burden of COVID-19, and as a research tool to correlate antibody responses with clinical outcomes.
Citations
Jun 28, 2020·Journal of Virology·John P Moore, P J Klasse
Aug 4, 2020·Lab on a Chip·Per Niklas HeddeWeian Zhao
Jul 18, 2020·Human Vaccines & Immunotherapeutics·Samuel A CohenOzlem Equils
Jul 11, 2020·The Cochrane Database of Systematic Reviews·Vanessa PiechottaNicole Skoetz
Oct 13, 2020·The Cochrane Database of Systematic Reviews·Khai Li ChaiNicole Skoetz
Jan 12, 2021·Journal of Proteome Research·Shalini AggarwalSanjeeva Srivastava
Feb 6, 2021·Scientific Reports·Tim A BrucknerBernadette Boden-Albala
Jan 13, 2021·Nature Medicine·Lisa E WagarMark M Davis
Mar 25, 2021·Scientific Reports·Christos FotisLeonidas G Alexopoulos
Apr 8, 2021·JMIR Public Health and Surveillance·Henry T PengAndrew Beckett
Dec 16, 2020·Journal of Clinical Microbiology·Dandan Li, Jinming Li
Apr 23, 2021·MSphere·Robert H BortzKartik Chandran
May 9, 2021·Journal for Immunotherapy of Cancer·Holden T Maecker
May 21, 2021·Nature Communications·Ge SongRaiees Andrabi
May 21, 2021·The Cochrane Database of Systematic Reviews·Vanessa PiechottaNicole Skoetz
May 25, 2021·Frontiers in Medicine·Yan MardianChuen-Yen Lau
Jul 17, 2020·ACS Sensors·Diana AlvesSimon R Corrie
Jan 19, 2021·ACS Omega·Natalia G HerreraSteven C Almo
Sep 8, 2021·Frontiers in Immunology·Luis A PeroniMarcio C Bajgelman
Oct 28, 2021·Microbiology Spectrum·David CameriniJoseph J Campo